ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01162668
Recruitment Status : Completed
First Posted : July 14, 2010
Last Update Posted : May 15, 2018
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
Katie McClendon, University of Mississippi Medical Center

July 13, 2010
July 14, 2010
May 15, 2018
April 2010
June 2014   (Final data collection date for primary outcome measure)
  • Weight loss [ Time Frame: 0, 6, 12, and 24 months ]
    change in weight from baseline
  • Body mass index (BMI) [ Time Frame: 0, 6, 12, and 24 months ]
    Change in body mass index (BMI) from baseline
Not Provided
Complete list of historical versions of study NCT01162668 on ClinicalTrials.gov Archive Site
  • ecomonic outcomes [ Time Frame: 0, 6, 12, and 24 months ]
    costs to the insurance plan were assessed
  • Systolic blood pressure [ Time Frame: 0, 6, 12, and 24 months ]
    change in systolic blood pressure from baseline
  • Diastolic blood pressure [ Time Frame: 0, 6, 12, and 24 months ]
    change in diastolic blood pressure from baseline
  • Medication use [ Time Frame: 0, 6, 12, and 24 months ]
    Change in mean number of medications prescribed
  • quality of life [ Time Frame: 0, 6, 12, and 24 months ]
    Impact of weight on quality of life (IWQOL-lite) questionnaire; tool assesses 5 domains of quality of life: physical function, self-esteem, sexual life, public distress, and work impact
  • Work productivity [ Time Frame: 0, 6, 12, and 24 months ]
    Work productivity and activity impairment questionnaire: General Health v2.0 (WPAI:GH) assesses work productivity
Not Provided
Surgery-related adverse events [ Time Frame: 24 months ]
Any surgery-related adverse events were noted
Not Provided
 
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees

Objective: to assess the health and economic outcomes (weight lost, change in control of chronic diseases such as diabetes, quality of life, work productivity, health care cost, etc) associated with bariatric (weight-loss) surgery for 200 severely obese patients who undergo bariatric surgery as part of the Mississippi State Employees' Life and Health Insurance Plan's Obesity Treatment Program (OTP).

2. Patient Characteristics: Inclusion criteria: Eligible bariatric surgical candidates who are enrolled in the OTP (100 patients per year for 2 years). The Plan's criteria includes, but is not limited to 1) enrollment in the plan for at least 12 consecutive months prior to September 1, 2009; 2) completion of the HealthQuotient health risk assessment through the Plan's wellness and health promotion program; 3) a Body Mass Index (BMI) of >40 kg/m2, or a BMI >35 kg/m2 with two or more co-morbidities such as diabetes, hypertension, sleep apnea or asthma; 4) two or more physician-supervised weight loss attempts within the last 24 months; 5) age 18 years or older; and 6) consent to provide personal and medical information to the Plan. Prior to surgery, each site administers a psychiatric evaluation to ensure the patient is psychologically stable for surgery. Exclusion criteria: any patient who does not meet criteria above or who declines to participate. Surgeries will take place only at Certified Bariatric Surgery Centers of Excellence (COE), of which, there are currently 3 in the state. The 3 COEs exist with 4 outpatient medical offices (1 COE is composed of 2 independent surgeon practices) Patients will be recruited at each site once they are approved by the OTP.

3. Design: prospective, observational, multi-center, longitudinal study of outcomes and resource utilization associated with OTP. Estimates of obesity and comorbidities' impact will be obtained from the outpatient medical office for the COEs. Medical charts, databases and medical/pharmacy claims will be the source of information. Surveys on quality of life, productivity, and patient satisfaction will be administered directly to patients. Database claim information will be obtained in future and is not a part of current IRB application.

4: Procedures: After obtaining informed consent, patients will be administered surveys at baseline, as well as at follow-up visits. Additional data will be obtained via patient charts, databases, and medical/pharmacy claims.

Not Provided
Observational
Observational Model: Other
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
200 obese patients with Mississippi State Employee Insurance who undergo bariatric surgery as part of Obesity Treatment Program
Obesity
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
165
200
June 2014
June 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Eligible bariatric surgical candidates who are enrolled in the Mississippi SSELHI Plan (100 candidates enrolled per year). The Plan's criteria includes, but is not limited to

    1. enrollment in the plan for at least 12 consecutive months prior to September 1, 2009
    2. completion of the HealthQuotient health risk assessment through the Plan's wellness and health promotion program
    3. a Body Mass Index (BMI) of >40 kg/m2, or a BMI >35 kg/m2 with two or more co-morbidities such as diabetes, hypertension, sleep apnea or asthma
    4. two or more physician-supervised weight loss attempts within the last 24 months
    5. consent to provide personal and medical information to the Plan

Exclusion Criteria:

  • Any patient who does not meet criteria above or who declines to participate.
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01162668
41165
No
Not Provided
Plan to Share IPD: No
Katie McClendon, University of Mississippi Medical Center
University of Mississippi Medical Center
Allergan
Principal Investigator: Katie S McClendon, Pharm.D. University of Mississippi Medical Center
University of Mississippi Medical Center
May 2018